Lymphangitis epidemiology and demographics

Revision as of 19:23, 20 October 2016 by Vishal (talk | contribs)
Jump to navigation Jump to search

Lymphangitis Microchapters

Home

Overview

Historical Perspective

Classification

Causes

Pathophysiology

Differentiating Lymphangitis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Case Studies

Case #1

Lymphangitis epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Lymphangitis epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Lymphangitis epidemiology and demographics

CDC on Lymphangitis epidemiology and demographics

Lymphangitis epidemiology and demographics in the news

Blogs on Lymphangitis epidemiology and demographics

Directions to Hospitals Treating Lymphangitis

Risk calculators and risk factors for Lymphangitis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vishal Devarkonda, M.B.B.S[2]

Overview

Clinically, lymphangitis being associated with other clinical manifestations, which vary from pathogen to pathogen. Incidence, prevalence and demographics of lymphangitis are poorly studied. Specific epidemiological and demo-graphical data for individual infections are discussed in detail separately. However, epidemiological and demo-graphical data of lymphangitis carcinomatosa is discussed below:

Epidemiology

  • Bruce DM and colleagues, reported that Intra-thoracic metastasis occurs in 30-40% patients with malignant disease, of which 6-8% develop lymphangitis carcinomatosa.[1]

Demographics

  • Bruce DM and colleagues, also reported higher prevalence of lymphangitis carcinomatosis in males compared to females(60:40), with higher prevalence reported in younger population.[1]

Template:WH Template:WS

  1. 1.0 1.1 Bruce DM, Heys SD, Eremin O (1996). "Lymphangitis carcinomatosa: a literature review". J R Coll Surg Edinb. 41 (1): 7–13. PMID 8930034.